Literature DB >> 7679697

Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.

D K Newton-Nash1, D D Eckels.   

Abstract

The valine-glycine dimorphism at position 86 of the DR beta-chain exhibited by most DR alleles has been shown to affect peptide binding. We demonstrate that DR1-restricted antigenic peptides differ in the extent to which binding is affected by amino acid substitution at positions 85 and 86 of the DR1 beta-chain. Binding of peptides derived from influenza hemagglutinin (HA306-320) and tetanus toxin (TT830-843) but not influenza matrix protein (MP19-31) was diminished on cells expressing DR1 beta-chains encoded by DRB1*0102 relative to DRB1*0101. The presence of tyrosine within HA306-320 and TT830-843 vs leucine within MP19-31 at a single DR contact position was revealed by alignment of the peptides according to a DR-binding motif. HA306-320 bearing leucine at this position (HA 306-320L309) bound to DR1 possessing either DRB1*0101- or DRB1*0102-encoded beta-chains suggesting that DR residues may discriminate among peptides based upon amino acid identity at a single position within the peptide. Furthermore, whereas all HA306-320-specific T cell clones recognized HA306-320L309 in the context of DR1 molecules possessing DRB1*0102-encoded beta-chains, some T cell clones failed to recognize HA306-320L309 in the context of DR1 molecules possessing DRB1*0101-encoded beta-chains. These results suggest that peptide conformation may also be affected by amino acid substitution at positions 85 and or 86 of the DR1 beta-chain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679697

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides.

Authors:  G Futaki; H Kobayashi; K Sato; M Taneichi; M Katagiri
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11.

Authors:  C I Pearson; A M Gautam; I C Rulifson; R S Liblau; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

3.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

4.  PRBAM: a new tool to analyze the MHC class I and HLA-DR anchor motifs.

Authors:  Anna Mestre-Ferrer; Erika Scholz; Jepi Humet-Alsius; Iñaki Alvarez
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

5.  Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules.

Authors:  R Kinouchi; H Kobayasi; K Sato; S Kimura; M Katagiri
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression.

Authors:  S Futami; N Aoyama; Y Honsako; T Tamura; S Morimoto; T Nakashima; A Ohmoto; H Okano; M Miyamoto; H Inaba
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

7.  Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.

Authors:  M P Davenport; C L Quinn; R M Chicz; B N Green; A C Willis; W S Lane; J I Bell; A V Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  A general model of invariant chain association with class II major histocompatibility complex proteins.

Authors:  C Lee; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft.

Authors:  C Lee; M N Liang; K M Tate; J D Rabinowitz; C Beeson; P P Jones; H M McConnell
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.

Authors:  Allen C Steere; William Klitz; Elise E Drouin; Ben A Falk; William W Kwok; Gerald T Nepom; Lee Ann Baxter-Lowe
Journal:  J Exp Med       Date:  2006-04-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.